📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Clostridioides difficile: innovations in target discovery and potential for therapeutic success. (2021)

First Author: Monaghan TM

Attributed to: LY256: A novel and potent antibiotic for treating Clostridium difficile infection funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/14728222.2021.2008907

PubMed Identifier: 34793686

Publication URI: http://europepmc.org/abstract/MED/34793686

Type: Journal Article/Review

Volume: 25

Parent Publication: Expert opinion on therapeutic targets

Issue: 11

ISSN: 1472-8222